Modeling INR data to predict maintenance fluindione dosage

被引:12
作者
Comets, E
Mentre, F
Pousset, F
Diquet, B
Montalescot, G
Ankri, A
Mallet, A
Lechat, P
机构
[1] CHU Pitie Salpetriere, INSERM, U436, Paris, France
[2] CHU Pitie Salpetriere, Serv Pharmacol, Paris, France
[3] CHU Pitie Salpetriere, Serv Cardiol, Paris, France
[4] CHU Pitie Salpetriere, Serv Hemostase, Paris, France
[5] CHU Pitie Salpetriere, Inst Physiopathol & Genet Cardiovasc, Paris, France
关键词
population pharmacokinetics; dosage individualization; anticoagulant treatment; Bayesian estimation; risk function;
D O I
10.1097/00007691-199812000-00009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This study was designed to construct a pharmacokinetic/pharmacodynamic model describing the evolution of International Normalized Ratio (INR) under oral anticoagulation treatment by fluindione in patients and to develop a method for individualization of fluindione dosage:. Three indirect response models describing the concentration-INR relationship were tested using a nonparametric estimation method. INR was modelled as a quantity being produced and eliminated. According to a log-likelihood ratio test, the evolution of INR was best modelled as an inhibition of its elimination by fluindione. The selected model was evaluated in 24 additional patients with INR measurements (after 2, 3, 4, 6, and 10 doses). Using a Bayesian method with data until day 4, INR was correctly predicted for days 6 and 10. The population characteristics of fluindione were estimated, pooling the two groups of patients. A Bayesian method for individualization of dosage regimen was developed, based on a risk function for INR at steady state. Prescription rules for fluindione were derived using this method retrospectively on the 73 patients in this study.
引用
收藏
页码:631 / 639
页数:9
相关论文
共 30 条
  • [1] Rapid and simple micromethod for the quantification of fluindione in human plasma using high-performance liquid chromatography
    Aymard, G
    Legrand, M
    Comets, E
    Mentre, F
    Diquet, B
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1998, 707 (1-2): : 169 - 173
  • [2] EVALUATION OF A BAYESIAN REGRESSION PROGRAM FOR PREDICTING WARFARIN RESPONSE
    BOYLE, DA
    LUDDEN, TM
    CARTER, BL
    BECKER, AJ
    TAYLOR, JW
    [J]. THERAPEUTIC DRUG MONITORING, 1989, 11 (03) : 276 - 284
  • [3] INTERINDIVIDUAL DIFFERENCES IN RESPONSE TO ORAL ANTICOAGULANTS
    BRECKENRIDGE, AM
    [J]. DRUGS, 1977, 14 (05) : 367 - 375
  • [4] Cazaux V, 1996, THROMB HAEMOSTASIS, V75, P731
  • [5] STEREOCHEMICAL ASPECTS OF WARFARIN DRUG-INTERACTIONS - USE OF A COMBINED PHARMACOKINETIC-PHARMACODYNAMIC MODEL
    CHAN, E
    MCLACHLAN, A
    OREILLY, R
    ROWLAND, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (03) : 286 - 294
  • [6] COMPARISON OF 4 BASIC MODELS OF INDIRECT PHARMACODYNAMIC RESPONSES
    DAYNEKA, NL
    GARG, V
    JUSKO, WJ
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (04): : 457 - 478
  • [8] PHYSIOLOGICAL INDIRECT RESPONSE MODELS CHARACTERIZE DIVERSE TYPES OF PHARMACODYNAMIC EFFECTS
    JUSKO, WJ
    KO, HC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) : 406 - 419
  • [9] KISTLER JP, 1990, NEW ENGL J MED, V323, P1505
  • [10] BIOLOGICAL RHYTHMS IN THE PHYSIOLOGY AND PHARMACOLOGY OF BLOOD-COAGULATION
    LABRECQUE, G
    SOULBAN, G
    [J]. CHRONOBIOLOGY INTERNATIONAL, 1991, 8 (05) : 361 - 372